Michael Lickver has a general corporate commercial practice and advises clients in a broad range of corporate and commercial matters, including debt and equity financings, private equity and venture capital transactions, mergers and acquisitions, corporate governance, shareholder arrangements, corporate reorganizations and public markets matters. Michael also has significant experience in the formation and structuring of several domestic and cross-border search funds.
Michael is also one of Canada's leading advisors in the medical marijuana industry created by Health Canada's Marihuana for Medical Purposes Regulations (MMPR) representing a variety of industry participants, including licensed producers, licensed producer applicants, licensed dealers, research and development labs, e-commerce platforms, seed-to-sale software developers, design and build firms, patient aggregators, equipment manufacturers and distributors, and agritech companies. Michael is also counsel to the Canadian Medical Cannabis Industry Association and Canadian Editor of the International Cannabis Law Journal.
Michael is currently an adjunct professor at Western Law where he teaches "Medical Marihuana: Law and Practice", a course he designed and developed with Hugo M. Alves and Vladimir Klacar.
- Daisy Intelligence in connection with various financings and related matters.
- Clearpath Robotics, in connection with numerous matters, including financings that included Canadian and U.S.-based venture capital investors.
- Nuralogix, in connection with its formation, acquisition of intellectual property assets, and various financings.
News & Speaking Engagements